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1INTRODUCTION
Calmodulin
Calmodulin (CaM) is a thermostable, monomeric, globular
protein with a molecular weight of 16,700 Daltons. In the
majority of species, CaM contains 148 amino acids with a
high proportion of acidic residues (fig.l), resulting in
an isoelectric point of 3.9 to 4. 3 (1-4). It was first
described by Cheung (4) i as an activator of the cyclic
nucleotide phosphodiesterase. Consequently, other
researchers refered to CaM as the: activator protein,
modulator protein, calcium dependent regulator protein and
troponin C-like protein.
CaM is now well accepted as the maj or calcium-binding
protein in non-muscle cells (4). Calmodulin appears to be
the most widely distributed (ubiquitous), extraordinarily
versatile calcium binding protein found in most, if not
all eUkaryotic cells (4). CaM is a highly coiled molecule
and has four putative calcium binding domains flanked by
two stretches of two helixes with a large sequence of
amino acids (1). CaM binds calcium with high affinity and
specificity, serving as the maj or intracellular calcium
receptor and having multifunctional regulation properties
for many cellular functions (1, 2). CaM invariably lacks
tissue and species specificity (2), another suggestion
2that it may be a universal regulator. Therefore, CaM is
considered to be the primary physiological receptor for
calcium in the eUkaryotic cells.
Literature Review
Bone Remodeling During Orthodontic Tooth Movement
The mechanisms by which mechanical forces activate cells
is not well understood. However, several decades of
extensive research established the fact that cell
activation occurs in, or through the plasma membrane (5).
Some factors that mediate the effects of extracellular
stimuli on their target cells are: calcium ions,
adenosine 3 t , 5 '-monophosphate (cyclic AMP) and guanosine
3 ' , 5 ,- monophosphate (cyclic GMP) , (5). These factors,
serve as intracellular second messengers in response to
plasma membrane interactions with extracellular agents
(first messengers).
The nature of the extracellular first messengers which
bring about tissue remodeling during orthodontic tooth
movement remains largely obscure. Indeed, bone remodeling
is considered to be a multifactorial process involving
different types of tissues, cells, many cell-derived
factors, and many cell-mediated metabolic events. Each
metabolic event occurs at its proper place and time.
3Therefore, control of bone remodeling involves the
complex interplay between stimulatory and inhibitory
factors, various cellular organelles and compartments,
intra and extracellular processes, organic matrix and
inorganic ions (6).
In vivo and in vitro studies have demonstrated that bone
remodelling is modulated by the classical mineral
regulatory hormones (parathyroid hormone, 1, 25-dihydroxy
vitamin D), local chemical mediators (prostaglandin E2,
osteoclast activating factor) and growth factors
(epidermal and platelet derived growth factors) among
others (5). It is known that several of these agents alter
the metabolism of second extracellular messengers, like
cAMP and calcium.
Specific CaM Distribution
Calmodulin is structurally conserved and functionally
preserved throughout the animal and plant kingdoms
(1,2,4,7,8). Calmodulin is a component of virtually every
intracellular compartment, as well as, the plasma membrane
of eUkaryotic cells (8). CaM has been found associated
with the plasma membranes of hepatocytes and the Purkinje
and granular cells of the rat brain (9,10). CaM has also
been associated with free ribosomes, smooth and rough
endoplasmic reticulum, nuclear envelope, vesicles,
4mitochondria (11), inner surfaces of post synaptic
membranes, microtubules, microtubule-organiz ing centers,
and the mitotic spindle apparatus (12).
In the rat CaM has been found in: cytoplasm, plasma
membrane of liver parenchymal cells (12) intestinal
epithelium (12), ciliated tracheal epithelium (13),
skeletal muscle (13), cytoplasm and nucleus of adrenal
cortex cells (12), heart (13), uterus (12), molar tooth
germ (14), within matrix vesicles derived by budding from
mineralizing cells of tibia epyphiseal shafts (15),
mandibular bone (15), mature and mineralizing chondrocytes
(15), new born calvarial osteoblasts and osteoclasts (16),
ROS (17/2.8) osteosarcoma cells (17), ribosomes (17),
rough endoplasmic reticulum (17), cytosol and plasma
membrane of the supranuclear region of secretory
ameloblasts (18), among other structures.
Calmodulin Functions and Suggested Mechanism of Action
The role of CaM in general is to detect the calcium
concentration transients that occur during normal cell
function and to then reflect the ambient calcium
concentration via regulation of various and mUltiple
processes (2).
In a resting cell, the available calcium concentration
5is in the order of 10-7 M to 10-8 M. Activation of the
cell, results in an increase in intracellular calcium to
about 10-6 M, or slightly higher. It is known that CaM can
detect calcium at this micromolar concentration and the
calcium binding constants for CaM do in fact have the
appropriate affinities. The large number of identified
CaM-dependent processes within one cell, requires that CaM
should be accessible to many cellular loci (1). The
presence of CaM in the cytoplasm and the mechanism of
regulation for most CaM dependent processes, that is
regulation by calcium dependent association and
dissociation, satisfy this requirement.
The majority of known CaM-dependent systems are
enzymatic. The general mechanism for the activation
(regulation) of a CaM dependent enzyme (E) is as follows:
nCa2+ + CaM = ca2+(n).caM + E = Ca2+(n).CaM*.E
(inactive) (active tertiary
complex)
The first step is an extracellular stimulus or messenger
which induces the binding of calcium to CaM. This induces
a large number of conformational changes in the protein
(2), that favor interaction and activation of the CaM-
calcium enzymatic complex, (CaM-ca2+ . E*). Therefore, the
inherent molecular flexibility of CaM may have a role in
6it's functional versatility (17). This flexibility gives
CaM the unusual capability of combining with and modifying
the properties of a wide spectrum of enzymes of very
different molecular characteristics, controlling mUltiple
basic cellular processes (17). Indeed, 16 possible CaM-
calcium complexes have been reported. The different
comformers may be active toward different enzymes
affording a variety of receptor specificities (1).
Fractional occupancy of the calcium binding sites may
dictate the systems regulated by CaM and help to explain
how this protein can be involved in diverse biological
processes (17).
Reduction of the intracellular level of calcium causes
dissociation of the tertiary complex, and a loss of
enzymatic activity. Of course, this type of reaction
mechanism and the regulation or activation of a given
enzyme depends on several factors. At limiting concentra-
tions of CaM or calcium, the concentration of the Calcium-
CaM complex will obviously be restricted. An increase in
either calcium or available CaM will shift the equilibrium
to favor the complex formation, and thus the apparent
calcium sensitivity of a given CaM-dependent system can
depend on the CaM concentration. The latter, in turn is
governed by the presence and concentration of other CaM
binding proteins and their binding affinities for CaM (1).
7Specific Calmodulin-Calcium Regulatory Processes
As stated before, the number and variety of systems that
are now thought to be regulated by CaM is remarkable. The
protein controls the metabolism and fuctions of cAMP and
calcium, coupling and integrating the two major cellular
messenger system on a molecular basis. As a mediator of
the calcium signal, CaM ensures the coordinated regulation
of metabolic pathways associated with calcium dependent
functions (1).
Calmodulin as the key Calcium Receptor Protein
Means et.al. (13) reported that CaM controls the effect
of calcium as a second messenger in stimulus-response
coupling. Increased or decreased intracellular calcium
concentrations have been implicated as a messenger between
the extracellular space and the cytosol. Kretsinger (20)
suggested that the sole function of intracellular calcium
is to transmit information, and that the target(s) of
calcium functioning as a second messenger is one or more
intracellular proteins. Examples of processes regulated by
the information of signals of intracellular calcium are:
platelet agreggation, neutrophil chemotaxis and phago-
cytosis, and mast-cell histamine secretion (1).
8Specific Calmodulin-Calcium Enzyme Regulation
CaM has no known intrinsic enzymatic activity but
it regulates a wide spectrum of enzymes that control many
fundamental cellular processes (18). It has multiple
binding or acceptor proteins, interacting at different
average degrees of calcium occupancy (3). Therefore, the
CaM-calcium complex represents the biologically active
state of intracellular calcium and mediates the calcium
regulation of a large number of fundamental intracellular,
and perphaps extracellular, metabolic pathways through
enzymatic systems in various tissues (1,18).
In addition to the RBC calcium-magnesium ATPase model of
regulation, other researchers presented evidence in which
CaM can also act indirectly on a variety of regulatory
systems such as several protein kinases (7,20), guanylate
cyclase (4), adenylate cyclase (1), brain cyclic
nucleotide phosphodiesterase (1), phosphol ipase A2 (4) ,
tryptophan hydrozylase (4), calcium-magnesium ATPase (1),
myosin light-chain kinase (1), phosphorylase b kinase
(1,4) NAD kinase (1,18), and brain membrane kinase (1).
Regulation of the Calcium-Magnesium ATPase by Calmodulin
Vicenzi (21) reported that CaM not only mediates the
effect of the cytoplasmic calcium signal but also
terminates the effects of the CaM-Calcium complex by
9regulating the intracellular free calcium concentration
via stimulation of calcium transport ATPases. Therefore,
by regulating calcium transport mechanisms, CaM modulates
its own function.
The extensively studied Calcium-Magnesium ATPase
(calcium pump) in the human red blood cell represents a
classical example of the CaM regulation on the calcium
transport (22 , 23) . Where as calcium readily enters the
cells, it's movement between organelles and removal from
cells is an active process (23). CaM was shown not only to
stimulate the ATPase activity of the calcium pump, but the
binding of the protein to the membrane also results in
calcium extrusion (23,24).
The data accumulated for the red blood cell suggests
that energy-dependent calcium removal is important in
maintaining calcium homeostasis and that CaM is intimately
involved in regulating this process. CaM should be able to
regulate the intracellular calcium level in a rather
specific manner.
At resting levels, free calcium concentrations are
normally about 10-7 M (1). At such concentrations, the
calcium binding sites on CaM are unoccupied. When a
stimulus increases this level to 5 micromolar or 10
10
micromolar, the CaM ion-binding sites become filled,
thereby converting the protein into an active conformation
(4) triggering the various CaM dependent cell reactions
(1). The Calcium-CaM complex associates with and activates
the plasma membrane Calcium-Magnesium pump, terminating
the cell activation by removal of calcium from the cytosol
(23) .
The operational Calcium-Magnesium ATPase then actively
transfers calcium from the cytosol to the outside of the
cell. When intracellular calcium levels are reduced below
the micromolar range, the sites on CaM empty, reversing
its conformation and its association with the Calcium-
Magnesium ATPase complex (23).
Thus, CaM has an additional involvement in the regula-
tion of the termination of the calcium message. CaM is a
transducer of the intracellular calcium message and this
certainly is the most straight forward analysis of it's
role. In the case of the regulation of the plasma membrane
Calcium-Magnesium pump, however, the effect of its action
is to help terminate the calcium message. Thus, high
intracellular calcium leads to accelerated removal of
calcium from the cytosol not only because calcium is a
substrate for the pump but also by its regulatory action
in binding to CaM (1).
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Finally in 1988, Takakuwa and Mohandas (25) reported
that calcium and CaM can regulate membrane stability
through modulation of skeletal protein interactions which
are dynamic in nature on intact membranes.
Regulation of Cyclic Nucleotides and Calcium Metabolism
Cyclic nucleotides and calcium are two major cellular
messengers whose functions and metabolism are closely
interwoven. For example, cAMP may sometimes serve as a
second messenger and calcium as a the third messenger,
whereas at other times, the roles of cAMP and calcium may
be reversed. In addition, the cyclic nucleotides may exert
their effect in concert with or in apposition to that of
calcium.
Therefore, in controlling the metabolism and function of
cAMP and calcium, CaM integrates the two messenger systems
on a molecular basis (18). Specifically, CaM can stimulate
the adenylate cyclase activity (ex. brain and kidney),
resulting in an increase in cAMP synthesis. On the other
hand, CaM also stimulates the phosphodiesterase activity
which would be expected to terminate the cAMP signal (18).
Thus, the system seems ideal for a pulse of calcium to be
translated into pulse of cAMP with a termination signal.
12
Regulation of Thyroid Hormone Action on Calcium-ATPase
Activity in vitro
Davis et.al. (26) found that this hormone action is CaM-
dependent and the complex of CaM and enzyme is stimula-
table by physiological concentrations of iodothyronines
(27). It has been proposed that thyroid hormone action on
the enzyme-CaM complex involves hormone-induced changes in
membrane fluidity in the domain of the enzyme.
possible Calmodulin Hormonal Control During Bone
Remodeling
Several researchers { Wong (28), Peck and Kohler (29),
Dziak, et.al. (30) } suggested that CaM-calcium dependent
reactions are involved in the PTH stimulation of bone cell
cAMP. It has been shown recently that during the release
of luteinizing hormone, the CaM concentration in the
target cell cytosol decreased with a concomitant increase
in the amount of CaM bound to the plasma membrane (29).
Calcium and calcium binding proteins, in particular CaM,
play major key roles in the regulation of the biology of
the mineralization process. CaM may provoke changes in
phosphates and calcium concentrations in plasma, which
affect bone remodelling and modify the reponse to para-
thyroid hormone in mineralized tissue.
14
osteoclastic and osteoblastic cells, via changes in CaM
activity. PGE2 may alter the subcellular distribution of
Calmodulin and produce some of its effects through this
action. They also stated that the CaM pool that is
involved in the mediation of the PGE2-induced effects on
calcium may be intracellular; but the pool involved in the
cyclic AMP effect may be membrane-bound and accessible to
antagonists.
Calmodulin-vitamin D Physiology
Bikle, et. ale (36) observed that 1,25 dihydroxyvitamin
D stimulated an increase of CaM content in chick duodenal
brush border membranes (without increasing total cellular
levels) in parallel with an increase in duodenal calcium
transport in vivo, and calcium uptake by brush border
membrane vesicles in vitro.
The results suggest that 1, 25 dihydroxyvitamin D leads
to a redistribution of CaM to the brush border membrane,
permitting CaM to mediate 1,25 dihydroxyvitamin D stimu-
lated calcium movement across the brush border membrane.
Perhaps CaM interacts with a 'calcium carrier or channel
in the membrane to facilitate calcium movement through the
membrane down it's electrochemical gradient (36).
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In 1986, Gronowicz et. ale (37) suggested that the
synthesis of intracellular calcium binding proteins is a
possible mechanism for the alteration of the cytoskeleton
and cell morphology characteristics of the ROS 17/2 . 8
cells. The author presented evidence for the effect of
1,25 dihydroxyvitamin D3 on the cytoskeleton of rat
calvaria and rat osteosarcoma (ROS 17/2 .8) osteoblastic
cells. Finally, it was reported that changes in the
cytoskeleton, as well as, cell proliferation have been
associated with altered gene expression and differen-
tiation and could participate in the response of
osteoblasts to 1,25 dihydroxyvitamin D3 (37).
possible Calmodulin Regulation of Calcitonin Activities
Calcitonin is known to inhibit osteoclast activity both
in vivo and in vitro (38,39). There is evidence that this
inhibition is mediated through an increase in intra-
cellular cAMP (39). Inhibition of secretion of rat
calcitonin by CaM antagonists has been reported. Cooper
and Borosky (40), suggested that CaM plays an important
role in the exocytotic process leading to extrusion of
calcitonin from the C-cell of baby rat thyroparathyroids
and probably of PTH from the chief cell, as well.
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Induction of Alkaline Phosphatase Activity by Calmodulin
Komoda et.al. (41-43) demonstrated evidence of a time-
dependent inductive effect of Calmodulin on the alkaline
phosphatase activity (ALP) which was inhibited specifi-
cally by CaM inhibitors. They proposed that elevated cAMP
concentration due to CaM functions may regulate the ALP.
Calmodulin Role in Plasma Membrane Transport
The biological function of the CaM-coated vesicle
association is unknown at this time. However, several
postulates are conceptually appealing. It may regulate the
calcium ATPase reported in coated vesicles (44,45),
mediated interactions between the coat structure, and the
membrane, assist in the assembly of the coat structure,
modulate interactions between coated vesicles and
cytoskeleton elements, and/or regulate the clustering of
receptor-ligand complexes into coated vesicles (44,45).
The authors presented biochemical and immunological data
which offer the possibility that CaM may regulate the
calcium requirement for receptor-mediated endocytosis.
They also showed, that radioiodinated CaM binds specifi-
cally to coated vesicles, in vitro.
Larsen et.al. (46) revealed that CaM is a component of
clathrin-coated vesicles isolated from brain and that the
association is calcium dependent and of high affinity
17
(kd=10-9 M). CaM stimulated the active transport of
calcium into inside-out vesicles of red blood cell
membranes, acting at the internal side of the membrane
bound ATPase (Regulation of plasma membrane calcium
transport) (46).
The mechanism has not been defined, however, it was
suggested that CaM is a soluble protein (not an intrinsic
membrane-bound protein) (46). Thus the possibility that
certain soluble proteins such as CaM, may interact with
the cytoplasmic face of the plasma membrane to modulate
active transport processes has been proposed. Activation
of the plasma membrane calcium pump would serve to
terminate the other calcium dependent functions. other
related studies have been published indicatory of CaM
involvement in the granule-plasma membrane fusion process
(44), presence of CaM in secretory vesicles (44), binding
of the protein to human erythrocyte ghosts and inside out
vesicles in a calcium dependent manner (47).
Calmodulin Antagonists Actions in Bone Metabolism
The binding of calcium to CaM exposes a hydrophobic
domain, which is essential for interactions with its
receptor proteins. The anti-CaM drugs appear to bind to
this exposed domain and interfere with CaM-receptor
interactions (indeed, the ability of these drugs to
18
inhibit CaM appears related to their hydrophobicity rather
than to their cl inical eff icacy) (43). Detailed
investigations of numerous analogues within these classes
of drugs have revealed common structural features (i.e., a
large hydrophobic region and a side-chain amino group,
which is separated by four or more atoms), thus enabling
the prediction of a generalized structure for a CaM
inhibitor (43).
Historically, phenothiazines antipsychotics were the
first drugs demonstrated to be CaM inhibitors (4). The
ever-expanding list of CaM inhibitors now includes other
antipsychotics, as well as, alpha-adrenergic blockers,
antidepressants, antihistamines, antimalarial agents,
cancer chemotherapeutic agents, local anesthetics,
neuropeptides, and smooth muscle relaxants (4).
Specifically, known CaM inhibitors include: phenothiazines
(trifluoperazine, chlorpromazine) (1,40,41,43,48,49),
propanolol (1), haloperidol (1), butyrophenones (1),
diphenylbutyl-amines (16), pimozide (1), calcineurin
(1,4), compound W-7 N-(6-aminohexyl)-5-CI-naphthalene
sUlphonamide} (1), and recently, a potent CaM inhibitor
called Calmidazolium (R-24571, Jansen Pharmaceutical)
(47) .
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In regards to possible roles for CaM antagonists in the
bone metabolism, Singh and Padmanabhan in 1979 (49)
demonstrated the effects of chlorpromazine (CPZ) on
skeletogenesis. The authors found that when a single dose
of CPZ (100mg/kg) was administered to pregnant rats on the
14th day of gestation (sperm positive=day 0), an inductive
intrauterine and extrauterine growth retardation was
observed. ossification was delayed by 1 to 3 days in the
long bones of the extremities, by 1 day in the scapulae
and by 2 to 3 days in the ileum (49).
In 1985, Komoda et. ale (41) presented evidence of the
inhibitory effect of CPZ and trifluoperazine (TFP) on bone
formation by in vivo and in vitro studies. Specifically,
these drugs showed a dose-dependent decrease in the
alkaline phosphatase activity (ALP), as well as, a
suppression of collagen synthesis in calvariae of rats.
These in yivo and in vitro findings, suggested that CPZ
inhibits osteoblastic cell function, reflecting its
mechanism of suppression in bone formation.
In addition to the effect of CPZ and TFP on osteoblastic
cell functions, an increased serum calcium and phosphate
levels in drug treated rats was observed, by a single
injection of these antipsychotics. Therefore, these
results may also indicate the possible involvement of
20
these tranquilizers in bone resorption where the increased
serum calcium and phosphate levels could be caused by
their release from bone tissues resulting from stimulation
of bone resorption (41). The authors attributed the
drug's actions to a rather specific inhibitory effect on
the ALP and not to general cytotoxicity, (the enzyme
activity was decreased further at higher concentration of
the drug, but on-the-other hand, the DNA and protein
contents stayed relatively constant throughout the
experiment) .
In 1986, Cooper and Borosky (40) reported an in vivo and
in vitro inhibition of rat calcitonin by CaM antagonists.
studies were designed to investigate the potential
importance of CaM in the release of calcitonin (CT) , in
response to an increase in the concentration of extra-
cellular calcium. The results showed that CaM antagonists
(TFP, compound W-7, CPZ, haloperidol) can inhibit the in
vitro secretion of CT and release of PTH as well.
In 1988, Komoda et ale (43) studied the acute effect of
CPZ on metabolic changes in rats. The drug was found to
markedly suppress the radioactive calcium incorporation
into the calvarium and ileum in vitro; increased the
calcium and phosphate (P) levels in the serum; increased
calcium, (P) and gamma-carboxylglutamate in the urine;
21
reduced the amount of alkaline phosphatase activity in
serum and urine; reduced serum concentrations of ionized
calcium, CT, 2S-hydroxyvitamin D3' 1, 25-dihydroxyvitamin
D3 and 24,2S-dihydroxyvitamin D3. C-T scan analysis of the
vertebrae showed 14% loss of bone density in the young
bone of the vitamin D-deficient rats treated for 10 days
with 10 mg of CPZ/kg of body weight (experimental group),
resulting in an enhanced action of bone resorption in
vivo. There was no change in serum and urinary creatine
levels during CPZ administration in vivo, indicating that
the above phenomenon does not reflect renal failure (43).
From the results of several markers for the generalized
bone turnover in the serum, it is believe that CPZ effects
may not be mediated through changes in the PTH or corti-
costerone levels, because in this experiment little if any
changes of mid-PTH and corticosterone concentrations were
observed.
Calmodulin:Possible Role in the Regulation of Exocytotic
Membrane Fusion
CaM has been found to bind to pre-formed exocytosis
sites and also being associated with the membranes of the
osmoregulatory system (50). In 1980, Perachia, et.al. (51)
reported that CaM could be involved in the regulation of
ionic transport processes (endocytosis) and lysosomal
functions associated with ciliary basal bodies. Localiza-
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tion of Calmodulin on the inside surface of the plasma
membrane of the sea urchin egg strongly suggested that CaM
is involved in exocytosis of cortical vesicles and confers
a high sensitivity for calcium on the exocytotic process.
Involvement of a CaM-like protein in the uncoupling
mechanism has been suggested (50-57).
Neurohormone Regulation by Calmodulin
Calmodulin stimulates vesicle neurotransmitter release
and protein kinase activity (58). In neuronal dentrite,
calcium transport in the smooth endoplasmic reticulum and
mitochondria is believed to be regulated by CaM (58).
Binding of CaM to Synaptic Vesicles (59)
Cathecolamine release involves movement of secretory
vesicles to the plasma membrane (exocytosis), requiring
fusion of the secretory granule membranes with the plasma
membrane and the subsequent extrusion of the soluble
granular contents to the exterior.
The process of secretion is one of the calcium mediated
events in which CaM seems to be involved. How CaM might be
involved in secretion remains to be determined. However,
the presence of calcium dependent CaM-binding in a variety
of secretory granUles and plasma membranes (60) may
suggest that CaM is involved either with the transport of
23
granules to release sites or with the interaction between
granules and plasma membranes during exocytosis.
Alternatively, CaM might be involved in the process of
retrieval of granule membranes after exocytosis. In this
regard, high affinity binding sites for CaM have been
found in coated vesicles from the brain (45). If
exocytosis is a true contractile event, cytoskeleton
proteins and their regulatory ones (ex. CaM) might be
involved (44).
Role of CaM in Cancer or Transformed Cells
Evidence over the past several years shows that CaM
levels are higher in transformed and rapidly dividing
normal cells and tissues than in their quiescent normal
counterparts (61,62), suggesting that CaM levels may have
a role in cell growth and malignant transformation.
In 1987, Rasmussen and Means (63) suggested than in
cells (or tissues) transformed by either oncogenic
viruses, chemical carcinogens or hormone treatment, the
level of CaM is consistently increased and that change of
concentration of CaM was a result of an enhanced rate of
CaM synthesis.
In 1982, when Wayne et. ale (64) compared several fast-
growing Morris hepatoma tissue lines with normal adult
24
liver tissue, the following observations were made: CaM
activity was increased in the cytoplasm and decreased in
the membranes of the tumor cells. Total calcium was
increased three to five fold in the tumors. Cycl ic AMP
phosphodiesterase activity was increased, where as cyclic
GMP phosphodiesterase activity was decreased. Therefore,
it is probable that the CaM-calcium complex is very active
in these rapidly growing tumors and may contribute to an
overall decrease in the tumor cell's ability to respond to
cAMP and an overall increase in the ability to respond to
cGMP. Also increased levels of CaM were observed in
fibroblasts transformed by Rous Sarcoma Virus due to an
increase in the rate of CaM synthesis.
Antagonists of Calmodulin inhibited cell replication of
VX2-L cell line (carcinoma cell line) (64). Transformation
of cells to malignancy appears to be one general mechanism
causing a specific increase in the intracellular content
of CaM. The initial report of such a change was made by
Waterson et.al. (62), who suggested that transformation of
chick embryo fibroblasts by Rous Sarcoma Virus (RSV)
resulted in an elevation of the activator protein of
phosphodiesterase (CaM). In these experiments, the protein
was quantitated by densitometric scanning of cytoplasmic
proteins distributed on polyacrylamide gels. A similar
study by La Porte et ale (65), utilized an identical
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system but, measured CaM by it's ability to stimulate
phosphodiesterase. Both reports suggested a doubling in
the concentration of CaM in the transformed compared with
the non-transformed cells. Cell cycle progression and cell
transformation is usually accompanied by characteristic
alterations in cell morphology, metabolic rate, cyclic
nucleotide metabolism, and intracellular calcium levels
(1). All of these processes are considered to be regulated
by CaM. In addition, transformed cells lose the require-
ment both for anchorage to a substrate and for the high
levels of extracellular calcium required for proliferation
by their non-transformed counterparts (61). Therefore,
many of the properties typical of transformed cells could
conceivably be a result of increased intracellular CaM
levels.
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Hypothesis
Calmodulin (CaM) is the major intracellular calcium
receptor. The distribution of CaM changes during
functional stresses on alveolar tissues, such as those
experienced when mechanical forces are applied to the
teeth.
Corollary:
1. In cells with CaM, the intracellular distribution of
this protein will change under stress conditions.
2. Specific cells within tissues under stress will show
increased concentration of CaM while others will show
decreased concentration.
General Objectives
1. To begin to design a potential model for possible
future characterization for the role and mechanism of
action of CaM in the bone remodelling process induced by
ortodontic tooth movement or bone pathologic conditions.
2. To study the relative distribution of CaM in the
different cellular and subcellular compartments of bone
active cells by two different approaches at the higher
possible resolution level of immunocytochemistry.
3. To demonstrate the efficacy of the proposed methods
in/on the tissues to be studied.
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specific objectives
1. To define the location of CaM in the maxillary bone
structures of male Sprague Dawley rats using light
microscopy immunofluorescence methodology.
2 . To define the intracellular location of CaM in ROS
(17/2.8) osteosarcoma-derived cells, using immunocyto-
chemistry at the light and electron-microscopic levels.
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MATERIALS AND METHODS
Rationale of Approaches Used
Since CaM appears to be a central regulator of calcium
mediated processes in cells, it's location inside the cell
may help determine it' s sites of action. It has been
demonstrated in the literature that the direct immuno-
fluorescence in combination with the Protein-A gold
approaches are well defined and established techniques
developed for a rapid assessment and location of intra-
cellular antigens for in vivo and in vitro systems. The
procedures are relatively fast, versatile, reproducible
and allows the screening of a large number of cells under
a variety of experimental conditions. Specifically, the
techniques have been used succesfully to localize CaM
showing a very high resolution, sensitivity and
specificity.
The techniques present a high resolution method for the
direct in situ localization of unique antigenic sites in
specific organelles. Although many biochemical studies
have examined CaM and CaM-binding proteins , relatively
little is known about the localization of these molecules
at the cellular level.
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An in vitro tissue culture model (ROS 17/2.8 cells) was
used as a test system to localize CaM. The reason for
using ROS cells is based on their potential osteoblast
lineage and their use as a model for the study of the
regulation of the bone remodeling process (66). The ROS
17/2.8 cells were derived from a rat osteosarcoma and have
several properties related to their origin from bone:
elevated alkaline phosphatase levels (an indicator of bone
formation and turnover), high sensitivity PTH stimulation
of adelynate cyclase, vitamin D receptors (showing vitamin
~3 regulated synthesis of osteocalcin), bone gamma-
carboxyglutamic acid protein synthesis, among other
characteristics (66). ROS 17/2.8 cells were also used
because: they are a convenient and economical source of
bone-like cells; the published studies by Dr. Paul Epstein
in which CaM has been purified from the ROS 17/2.8 cells
by fluophenazine sepharose affinity chromatography (17);
the ROS 17/2.8 cells were available from Dr. Barbara
Kream.
Immunofluorescence study in Rat Alveolar Bone Cells
One hundred male Sprague Dawley rats (Hilltop Animal
Lab, Indianapolis) weighing approximately 200g each, were
maintained under the same environmental and nutritional
conditions. All rats were under general anesthesia with
Ketamime 40 mg/Kg + 10mg/Kg Xylazine, for 1 hour (67).
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Fifty rats served as a control group, while the other 50
animals were subjected to orthodontic tooth movement, by
the insertion of a piece of elastic band (.25mm in
thickness) between the maxillary right first and second
molars (modified Waldo's technique) (fig. 2-3). The
maxillary right quadrant of the rat's dentition was
arbitrarly chosen as the experimental side and the
maxillary left quadrant as an internal control. After
three days of orthodontic tooth movement, all rats were
sacrificed. Maxillae from both experimental and control
groups were dissected (fig. 4), fixed overnight with
Zenker's fixative, and decalcified for five days with 0.5M
EDTA. Specimens were dehydrated with a graded series of
ethanol (70%, 95%, and (2x) in 100%) for thirty minutes,
each. Finally, specimens were transferred to xylene for
fifteen minutes prior the one hour and three changes
embedding in paraffin. sections of 4 microns were prepared
from the mesial root area of each first maxillary molars.
For the immunological procedures, the primary antibody
(sheep anti-native bovine testes Calmodulin) was obtained
from Biomedical Technologies, Inc., Stoughton, Ma.(BT-570)
and precipitated and purified by affinity chromatography.
The secondary antibody (rabbit anti-sheep IgG-FITC) was
supplied by Organon Teknika Co., PA.,( Cat.no.1214-0082).
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The paraffin sections were preincubated with 1.5% highly
purified bovine serum albumin (cat. no. A-7030 Sigma, ST
Louis), dissolved in phosphate buffer solution (PBS)
(pH=7. 4) for thirty minutes, incubated for one hour at
37°C with a (1:10) sheep anti-rat CaM IgG (primary
antibody), washed for fifteen minutes with PBS (3X-5 min,
pH=7.4) and incubated with the secondary antibody (1:100
rabbit anti-sheep IgG with fluorescein isothiocynate-
conjugated), for thirty minutes. Finally, the sections
were washed in PBS, for thirty minutes, (3x-10 min).
The antigen-antibody reaction, as well as, the immune
complex between the primary and the secondary antibodies,
was assesed and their specificity demonstrated, by various
immunocytochemical experiments:
1. Incubation of sections directly with the secondary
antibody omitting the primary antibody to identify non-
specific binding of the secondary antibody to the tissue
sections.
2. Incubation of sections with a non-reactive antibody
(IgG) previously absorbed (neutralized) with an excess of
it's pure antigen (5-10 fold excess), instead of the
active antiserum, followed by the secondary antibody to
verify the specificity of the antigen-antibody interaction
by revealing any non-specific binding of the secondary
antibody to the tissue sections. The pre-absortion of this
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neutralized antibody was achieved through an incubation of
antigen with antibody for 30 minutes at 37 0 C and then
overnight at 40 C by using an empirically defined 5-10
fold excess of the optimal ratio of the antigen to
antibody interaction.
3. Incubation of sections with non-immune normal sheep
serum followed by the secondary antibody to verify the
specificity of the antigen-antibody interaction.
4. Incubation with a non-sense antibody (anti-human alpha
amylase, cat. no. A-8273) obtained from Sigma, ST Louis
and directed against antigens known to be absent in the
ROS 17/2.8 cells, followed by the secondary antibody to
verify the specificity of the antigen-antibody inter-
action.
* To avoid or decrease possible non-specific binding of
the antibodies to the cells structures, antigen-affinity
purified antibodies were used, but also a preabsortion of
the secondary antibodies on the cells prior to its use was
employed (68). Specifically, 300 microliter of the FITC-
secondary antibody were carefully spread over the cells
and incubated at 37 0 C for one hour (in the dark for the
FITC). The supernatant containing the IgG molecules was
collected and the procedure repeated on a second sample of
cells. Finally, the IgG was collected and diluted to
appropiate working concentrations.
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For the examination with the fluorescence microscope the
evaluator limited the field of observation to the mesial
root of the first upper molar (mesial and distal
surfaces), and to the inter-radicular septum of the same
tooth. The preparations were examined and photographed
using Kodak Ektachrome ASA 200 film on a Nikon Optiphot
microscope equipped for fluorescence photography. The
evaluator was not informed of which group was being
examined.
Cell Culture of the ROS 17/2.8 Cells
ROS 17/2.8 cells, a permanent line in continous culture
since April, 1980 and obtained from a rat osteosarcoma
(69), were cultured in F-12 medium supplemented with 5%
fetal bovine serum (FBS) and 0.1 mg/ml Kanamycin sulfate
in a humidified atmosphere of 95% air and 5% carbon
dioxide (70). Cells were fed every 3-4 days with the
mentioned culture medium.
Immunofluorescence study in Res 17/2.8 Cells
Cells grown on round coverslips (18 mm diameter)
obtained from will Scientific, Inc., Rochester, NY (cat.
no. 2-180) and 12-wells tissue culture dishes obtained
from Costar, Cambridge, MA (cat. no. 3512) for 4 days at
37oC. Most procedures were performed at room temperature,
or otherwise specified. Cells were counted on a hemo-
34
cytometer and washed extensively with Dulbecco's PBS
(pH=7.0) containing: 8.0g sodium chloride, 0.2g potassium
chloride, 1.15g sodium phosphate (dibasic), 0.2g potassium
phosphate (monobasic) per liter.
Cells were either fixed with freshly prepared 2%
paraformaldehyde for 30 min or with cold absolute methanol
for 5 minutes at -20oC (68,71) and sUbsequently rinsed
(3X) throughly with PBS. Cells fixed with 2% parafor-
maldehyde were made permeable with 0.1% NP-40 (Sigma, st
Louis) in stabilizing buffer (lmM EGTA, 100mM PIPES, 1%
Polyehylene glycol) for 30 min and followed by further
rinsing in stabilizing buffer. All fixed cells were rinsed
( 3X) with PBS containing 1% BSA obtained from Sigma, ST
Louis, (cat. no. A-7030). All samples were then rinsed
with PBS and incubated with 1.5% BSA for 30 min.
For the indirect immunofluorescence staining a
polyclonal sheep anti-bovine testes CaM IgG diluted (1:10)
with PBS (72) and obtained from Biomedical Technologies,
Inc., stoughton MA, (cat. no. Bt-570), was used for one
hour as the primary antibody incubation. The IgG was
affinity purified on a bovine testes on CaM sepharose
column. Following this incubation, the cells were rinsed
(3X) with PBS.
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A rabbit anti-sheep IgG (H&L chains) conjugated to
fluorescence isothiocyanate (FITC) (Organon Teknika
Corporation, West Chester, PA cat. no. KS 116-02-Fl) was
used as the secondary antibody. This IgG was isolated by
ammoniumsulphate precipitation followed by ion exchanged
chromatography in PBS (pH=7. 2) and conjugated to FITC
according to the method of The Feltcamp Immunology (73).
After conjugation, free FITC was removed by means of
dyalisis and gel filtration. Before being used for the
secondary incubation, the IgG-FITC was again purified in
our laboratory by passage through a Sephadex G-25 column.
The cells were finally incubated with a 1:100 dilution
of the secondary antibody in PBS for half an hour and then
rinsed (3X) with PBS. The experimental and control samples
were mounted on glass slides using 1:10 PBS:glycerol
(pH=7.0) and containing O. 05% phenylene diamine as an
antibleach. The slides were allowed to dry for at least 12
hours at a temperature of 4oC.
The antigen-antibody reaction, as well as, the immune
complex between the primary and the secondary antibodies,
was assesed and their specificity demonstrated, by various
immunocytochemical experiments:
1. Incubation of sections directly with the secondary
antibody omitting the primary antibody to identify non-
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specific binding of the secondary antibody to the tissue
sections.
2 • Incubation of sections with a non-reactive antibody
(IgG) previously absorbed (neutralized) with an excess of
it's pure antigen (5-10 fold excess), instead of the
active antiserum, followed by the secondary antibody to
verify the specificity of the antigen-antibody interaction
by revealing any non-specific binding of the secondary
antibody to the tissue sections. The pre-absortion of this
neutralized antibody was achieved through an incubation of
antigen with antibody for 30 minutes at 37 0 C and then
overnight at 4 0 C by using an empirically defined 5-10
fold excess of the optimal ratio of the antigen to
antibody interaction.
3. Incubation of sections with non-immune normal sheep
serum followed by the secondary antibody to verify the
specificity of the antigen-antibody interaction.
4. Incubation with a non-sense antibody (anti-human alpha
amylase, cat. no. A-8273) obtained from Sigma, ST Louis
and directed against antigens known to be absent in the
ROS 17/2. 8 cells, followed by the secondary antibody to
verify the specificity of the antigen-antibody inter-
action.
* To avoid or decrease possible non-specific binding of
the antibodies to the cells structures, antigen-affinity
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purified antibodies were used, but also a preabsortion of
the secondary antibodies on the cells prior to its use was
employed (68). Specifically, 300 microliter of the FITC-
secondary antibody were carefully spread over the cells
and incubated at 37 0 C for one hour (in the dark for the
FITC). The supernatant containing the IgG molecules was
collected and the procedure repeated on a second sample of
cells. Finally, the IgG was collected and diluted to
appropiate working concentrations.
The preparations were examined and photographed using
Kodak Ektachrome ASA 200 film on a Nikon Optiphot
microscope equipped for fluorescence photography. All
other chemicals otherwise not specified were purchased
from Sigma (st Louis, MO).
Immunoelectronmicroscopy Study in ROS 17/2.8 Cells
Cells were fixed with freshly prepared 1% para-
formaldehyde diluted in distilled water or with .1M
phosphate-buffered, 1% glutaraldehyde solution. After
fixation, all cells were rinsed with .1M phosphate-buffer
(pH=7.4) , dehydrated in a graded series of ethanol (70%,
90%, and 2X in 100%), rinsed twice with propylene oxide
and embbeded in Poly Bed 812. Thin sections were mounted
on nickel grids and processed for immunocytochemistry.
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it's pure antigen (5-10 fold excess), instead of the
active antiserum, followed by the secondary antibody to
verify the specificity of the antigen-antibody interaction
by revealing any non-specific binding of the secondary
antibody to the tissue sections. The pre-absortion of this
neutralized antibody was achieved through an incubation of
antigen with antibody for 30 minutes at 37 0 C and then
overnight at 40 C by using an empirically defined 5-10
fold excess of the optimal ratio of antigen to
antibody interaction.
3. Incubation of sections with non-immune normal sheep
serum followed by the secondary antibody to verify the
specificity of the antigen-antibody interaction.
4. Incubation with a non-sense antibody (anti-human alpha
amylase, cat. no. A-8273) obtained from Sigma, ST Louis
and directed against antigens known to be absent in the
ROS 17/2.8 cells, followed by the secondary antibody to
verify the specificity of the antigen-antibody
interaction.
* To avoid or decrease possible non-specific binding of
the antibodies to the cells structures, antigen-affinity
purified antibodies were used, but also a preabsortion of
the secondary antibodies on the cells prior to its use was
employed (68). Specifically, 50 microliter of the Protein-
A gold were carefully spread over the cells and incubated
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at 37 0 C for one hour. The supernatant containing the IgG
molecules was collected and the procedure repeated on a
second sample of cells. Finally, the IgG was collected and
diluted to appropiate working concentrations.
Management of possible Technical Problems. Pitfalls
Artifacts During The Research (74)
1. The use of nickel grids avoided oxidation of the metal
and consequent contamination of the tissue sections.
2. To obtain maximum specificity of the immunoreaction and
to reduce potential source of background, highly purified
and very specific immunoreactive agents were used. Using
high-titer antibodies allowed the use of lower concentra-
tions of the secondary antibodies while still retaining
good specific label patterns. This results in lower levels
of non-specific binding of the secondary antibodies to the
background.
3. To test the non-specific staining several control
experiments were run in parallel with the experimental
tissue sections.
4. Drying of the sections or evaporation of the reagents
during or between the incubations was avoided to decrease
any artifactual adsorbtion and/or clustering of the
colloidal gold.
5. To decrease the potential for background staining, the
incubations were performed by floating the grids on the
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different reagents to avoid exposure of both sides of the
grids to the antibodies or to the protein-A gold complex.
In addition, preincubation with highly purified 1.5% BSA
(cat. no. A-7030, Sigma, st Louis) also reduced the
background staining.
6. Experimental dilution controls were performed, both for
the primary antibody and the protein-A gold complex since
the concentration of the antisera and staining reagent can
also influence the specificity of the reaction. In parti-
cular, high concentrations increase the background and may
induce the formation of electron-dense deposits on the
tissue sections and their intense labeling by gold
particles, as well as the clustering of the gold
particles.
7. Harsh rinsing of sections may remove or displace the
specific labeling. Rinses were performed by gently
floating the grids on the reagents. The use of a glass
washing spot plate was used when jet washing was employed
avoiding direct flow of the jet on the tissue sections.
8. The quality of the tissue and the sections was care-
fully controlled. Indeed, suboptimal ultrastructural
preservation, necrotic cells, cellular debris, or broken
structures have the tendency to adsorb the gold particles.
Similarly, imperfections such as "chatter", scratches, or
dirt particles will interfere with the washing and will
accumulate the gold particles.
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9. The resolution of the precise location of the antigen
depends on the size of the gold particles. The smaller the
particle the higher the resolution obtained. Theoreti-
cally, the optimal resolution which can be achieved is in
the range of 5 to 15nm. However, the choice of the gold
particle size should be made in accordance with the type
of labeling required (75). In this research, 15 nano-meter
gold particles were used.
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RESULTS
In any histochemical study, the specificity of the
staining technique is always open to question. The
accessibility of immunoreactive sites is influenced by
both location of the antigen and the penetrability of the
tissue. In addition, it is well established that fixation
and embedding procedures alter protein antigenicity (75);
therefore, comparison of data from different structures
may be hampered by the phenomenom of different penetration
depths of the immunoreaction in loose and compact
structures. For these reasons, it was necessary to
determine optimal conditions for each antigen evaluated. A
variety of fixation protocols and the effect on
antigenicity assayed by ELISA analysis would be used for
future studies. The fixation procedure which preserves
maximal CaM antigenecity and provides good tissue
architecture was used.
Alveolar Cells-Histological Results
Observation of the condition of the bone in normal rats
in which no tooth movement was undertaken, revealed a
randomness of bone trabeculae, a moderate cellularity and
relative uniformity in the thickness of the periodontal
membrane. In experimental animals subjected to the
placement of the elastic, definite separation was obtained
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in twenty-four hours, and maximal separation in three
days.
The elastic changed the first molar from a normal distal
drift to a mesial direction of movement and, of course,
accentuated the normal distal movement of the second
molar. The areas of pressure and tension at the cervical
level, compared to the apical level, indicated that the
elastic strip produced a tipping kind of movement.
At twenty-four hours after placement of the elastic, a
definite reaction to stress, namely, changes in the width
of the periodontal membrane, cellular infiltration into
the bony plate adjacent to the ligament and changes in the
vascularity of the periodontal membrane was observed.
Pressure areas showed a narrowing of the periodontal space
and a localized vasoconstriction, whereas, in areas of
tension the opposite was true, that is, a widened space
with slight vasodilatation.
After three days, the tissue response was near maximum
with undermining resorption and bone apposition. It
resulted in an interesting aspect, an occlusal adjustment
observed in the lower non-experimental quadrant where a
slight tipping movement occurred for a possible restora-
tion of normal masticatory function.
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Alveolar Cells: Immunofluorescence Results
Upon examination of the sections obtained from all the
specimens, the presence of anti-CaM fluorescense was
observed in different areas: tooth pulp (fig.5), root
canal (fig.6,7), cemento-enamel junction (fig.6), alveolar
mucosa (fig.6), periodontal ligament (fig.7,9-11),
alveolar bone (fig.8), interradicular septum (fig.9),
alveolar bone lacunae (fig.12) and maxillary first molar
sulcular area (fig.13) .
All the control sections (fig. 14) studied showed some
generalized non-specific areas of low level fluorescense.
ROS 17/2.8 Cells-Histological Characteristics
On basis of Dr. Kream' s continous evaluation of the
characteristics and behavior of the ROS 17/2.8 cells it is
reported that these cells consistently demonstrate
osteoblastic properties. In culture, the cells form
contiguous layers covering the surfaces of the plastic
dishes as described by Rodan and Rodan (fig.15) (66).
The intracellular organelles of the ROS 17/2.8 cells are
typical for cells actively engaged extensively in protein
synthesis and secretion (66). The oval nucleus is located
at some distance from the matrix-secreting surface and the
space between the two is occupied by organelles involved
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in protein synthesis and transport, abundant rough
endoplasmic reticulum and Golgi apparatus (66).
ROS 17/2.8 Cells-Immunofluorescence Results
Previously Immunofluorescence data in cultured cells has
suggested that CaM is widely distributed including
cytoplasmic structures (1 , 4 , 76), membranes (1), nuclear
structures (12), as well as extracellular space (76). In
this study the ROS 17/2. S cells presented a surprising
intense immunofluorescence staining in the nuclear
compartments (fig.16,17) but very faint cytoplasmic
labeling. The control sections (fig.1S-21) demonstrated no
nuclear staining and very faint cytoplasmic labeling maybe
attributed to fixation procedures.
In the system used in this study, the experimental group
revealed an amplified sensitivity of the immunofluores-
cence technique to detect anti-CaM location in the nucleus
where as the controls demnonstrated a decreased level of
detection in terms of the amount of CaM present in the ROS
17/2.8 cells.
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Electron-microscopy study: Protein-A gold Technique in the
Ras 17/2.8 Cells
Description of the Protein-A Gold Immunocytochemistry
Protein-A is a cell wall constituent produced by most
strains of Staphylococcus Aureus (74,75) and consists of a
single polypeptide chain having a molecular weight of
42,000 Daltons, (77). The protein-A-immunoglobulin (Ig G)
interaction is a rapid pseudo-immune reaction (reaches
saturation level in about 30 minutes) and does not
interfere with the binding of the antibody to its antigen.
The high specificity of this technique is based on the
particular and unique ability of protein-A to interact and
bind with high affinity to the Fc fragment of Ig G from
almost all mammals (75).
MUltiple antigens can be localized in a tissue section
by a simple extension of the immunolabelling procedure
(75). Protein-A gold complexes are very specific reactive
immunoreagents (75). Theoretically, the resolution of the
Protein-A technique is determined by: the distance between
the antigen binding site and the Fe-terminal end of the Ig
G molecule (10 nm), and by the size of the Protein-A
molecule diameter of the gold particle used (75). The
combination of ultra-thin sections and the Protein-A
marker offers optimal conditions for a sensitive
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immunoreaction (77). This technique represents a powerful
and versatile method which can be successfully applied to
protein secretion and intracellular distribution.
Advantages of the Frotein-A Gold (FAG) Technique (74)
1. PAG is a negatively charged hydrophobic sol, formed by
electron dense properties (strong emission of secondary
electrons easily visualized). It is suitable for high
resolution electron-microscopic studies on intracellular
antigens for both TEM and SEM.
2. Low non-specific binding.
3. Useful for mUltiple marking studies ex: (double
labeling in the same tissue section, is possible).
4. Since the marker is particulated, it does not mask the
labeled organelle, thus allowing for good identification,
high resolution and the possibilities of quantitative
evaluation.
5. Valuable tool for ultra-structural analysis of cell and
tissue morphology.
Although it is reported in the immunofluorescence
literature that in the cultured cells most of the protein
is uniformly distributed throughout the cytoplasm (72),
some of it has also been associated with nuclear
compartments (12).
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The fixation procedures used in this study resulted in
an overall good preservation of the cellular structures
and the protein-A gold technique demonstrated the specific
localization of Calmodulin in the ROS 17/2.8 cells. As
illustrated in the experimental electron-micrographs
(fig.22-26) specific anti-CaM-Protein-A gold particles
were observed on the nuclear and cytoplasmic structures of
the rat osteosarcoma cells when compared to the control
electron-micrographs (fig.27-30). The statistical analysis
of the experimental vs the control sections is demons-
trated in (Table I).
The nuclear compartment demonstrated the highest
localization of anti-CaM-Protein-A gold particles with a
mean=28.01 while the cytoplasm showed a an average of 20.0
gold particles per section studied. The surrounding
plastic revealed a insignificant number of protien-A gold
particles (Table 1).
For the examination of the control sections I randomly
selected areas were arbitrarly chosen for the photograph.
The control sections I revealed no immunolabel ing on the
nucleus and virtually no immuno-staining was found in the
cytoplasm or the embbeding material (Table 1).
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DISCUSSION OF THE RESULTS
Immunofluorescence study in the Periodontium of the Rat
Alveolar structures
The observation that anti-CaM fluorescence staining was
not found in the controls but present in the experimental
samples may reflect a possible specific reaction of the
immuno-cytochemcal procedures. The presence of CaM in the
tooth and periodontium may suggest that this
multifunctional calcium binding protein is involved in
enzymatic processes associated with bone growth and
remodeling. However, though possible valuable indicators
of function-specific CaM location, these experiments do
not allow assessment of CaM in a specific type of cell.
Therefore, the design using light microscopy or even with
a biochemical analysis can't be used to test the
hypothesis of CaM re-distribu- tion in cells within
tissues mantain under stressfull conditions.
If and how calmodulin is involved in the bone remodeling
mechanism after applying orthodontic tooth forces has yet
to be clarified. Therefore, further studies as the study
of dose related-inhibitory effect of calmodulin as a
mediator of the cell division and transformation
mechanisms would be realized.
change its intracellular
in order to respond to
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Immunofluorescence study in the ROS 17/2.8 Cells
The finding of CaM mainly in the nuclear components is
consistent with some recent reports in the literature (12,
72,78). Several immunofluorescence studies have reported
nuclear staining of CaM in culture cells (72,78), as well
as in the nucleus of liver adrenal cortex cells (12). In
1980, Harper et. ale (12) observed that the administration
of hormones such as ACTH produced a large increase in
nuclear CaM staining relative to dexamethasone-treated
rats. It seems that CaM may
location to specific organelles
certain functional demands.
In the same study, the authors (12) reported that
increased nuclear CaM localization occurred in liver after
hormone stimulation. They suggested that hormones may act
not only through the regulation of the intracellular
calcium but through regulation of CaM as well. Especially
intriguing is the possibility that hormone regulation of
nuclear function could be accomplished through alterations
of CaM location.
The functional significance of nuclear CaM in the ROS
17/2.8 cells is unknown at this time. Although several
studies have reported a consistent pattern of nuclear
localization of CaM, in most cases, we can only postulate
52
as to the significance of CaM localization in any parti-
cular cellular compartment.
The fraction of all cellular CaM actually localized by
the immunofluorescence technique is unknown. Soluble CaM
is surely lost from the tissue during washing steps, so
that only a small percentage of total CaM is visualized.
It is appealing to postulate that active CaM is pre-
ferentially retained in tissue section, because
formation of CaM-receptor complexes are known to occur
only in the presence of calcium (1,4). Thus, calcium-CaM
complexes would be more likely to be bound to a component
of the cellular structure than would calcium-free CaM.
Therefore, the calcium-CaM complex might be less likely to
be removed during washing procedures.
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SUMMARY AND CONCLUSIONS
Immunofluorescence-Immunoelectron-microscopy Studies
In conclusion, from the experience obtained in this
research proj ect, there are many potential pitfalls in
immunogold labelling with small gold probes or with
immunofluorescence labelling, which can give non-specific
binding problems. Although it is difficult to eliminate
non-specific binding completely, application of
strategies suggested in these experiments yields
acceptably low backgrounds and clear labelling patterns at
both the light microscopy and ultrastructural levels.
The indirect immunofluorescence and the immunoelectron-
microscopy (protein-A gold) techniques demonstrated a
similar specificity to localize CaM in the ROS 17/2.8
cells. The decreased immunolabeling found in the cytoplasm
of the ROS 17/2.8 cells by the immunofluorescence
technique might be related to the fixation procedures used
in the procedure. Another possible explanation to this
finding is that the intense nuclear staining obtained in
the nucleus may obscured the cytoplasmic labeling and
provoked a contrast of immunofluorescence between the
nucleus and the cytoplasm.
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Despite little or no immunofluorescence staining of the
cytoplasm, significant immunogold labelling of the
cytoplasm was found. This apparent contradiction may
reflect the increased sensitivity of the protein-A gold
procedure vs the immunofluorescence technique or maybe due
to differences in fixation procedures. Because a careful
morphometric analysis was not realized in these pre-
liminary studies (ex. number of gold particles counted in
a corrected unit area), it is possible that the relatively
high level of immunostaining seen in the cytoplasm, is a
statistical artifact.
Calmodulin possible Re-distribution in Normal or
Transformed Cells
Compartmentalization of CaM has been suggested by
studies demonstrating that the ratio of CaM content in
soluble versus particulate cell fractions differs between
tissue types, as well as, by studies with fluorescent
labeled CaM reagents in intact or transformed cells (61).
The concept of regulation through CaM interaction-
dependent redistribution is also supported by evidence
suggesting that the spectrum of CaM-binding proteins may
change during cell growth, transformation, differentiation
and ectopic response to stimulation by hormones or other
factors (61).
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Several lines of evidence suggests that CaM may
dynamically vary its distribution between soluble and
particulate fractions as cell divide. These observations
support the concept that shifts in CaM location to
different subcellular fractions may represent a change in
intracellular CaM distribution. The cytosol-to-membrane
ratio of CaM may also varies with cell density in some
cuItures, and different distribution of CaM have been
observed in quiescent versus dividing cells (61).
The random diffuse distribution found in the immuno-
electron-microscopy study does not of course, directly
imply a freely soluble condition, since much of this CaM
is maybe bound to proteins that are themselves diffusely
distributed. The association of CaM with membranes or
other immobilized cytoplasmic elements in a non-
concentrative fraction would also be consistent with this
data. However, the presence of CaM in vesicles or
structures rapidly formed and collapsed in seconds,
suggests that at least some of the protein or the proteins
to which it is bound move through the cytosol freely (21).
Significance of the Project to the General Health Field
1. Similar studies with CaM have not been conducted in
bone cells.
2. This research may be used in the future as a
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preliminary approach to study the bone remodeling
mechanism using CaM regulatory substances to ultimately
optimize the rate of tooth movement during orthodontic
treatment. The intelligent use of this knowledge, will
permit us to modify the orthodontic mehtodology in order
to achieve an optimum tissue response through the
developing of innovative approaches in the future.
Therefore, accurate and precise control of tooth movement
can be optimized not only with the proper use of mechanics
but with knowledge of the subsequent biological response.
3. The practical contribution of this research to
pharmacology may well be a better understanding of the
actions of drugs and a more enlightened search for better
ones. Information in how certain drugs affect biochemical
pathways controlled by CaM should stimulate further
progress in therapeutic research. It is suggested that
calcium blockers and anticalmodulin antagonists might be
powerful anticancer and/or antihypercalcemic agents for
malignant bone diseases, such as, osteosarcomas. It may be
possible in the future, the development of effective
treatments designed to modify the CaM levels in the human
body.
4. In terms of the orthodontic-pharmacology fields,
patients under antipsychotic drug treatment would be
advise to take the neccesary medical precautions to avoid
secondary unexpected reactions to the orthodontic tooth
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movement treatment.
Unanswered Questions and Suggested Future Investigations:
The biological role of CaM in bone cells remain largely
obscure. But, extrapolating from its known role in other
cellular systems, this protein is likely to regulate
various calcium dependent cell processes in bone. In
further studies, therefore, CaM binding proteins or CaM
binding enzymes should be investigated in nlineralizing
tissues.
At present, most of the data concerning CaM regulation
must be considered as phenomenological. What is now
required is a concerted effort to understand the chemical
basis for each of CaM's actions. This will require
isolation and purification of the enzyme systems regulated
by this protein. Indeed, some success has already been
achieved along this lines.
The histochemical and cytochemical demonstration of CaM
in ROS 17/2.8 cells, as well as, alveolar cells give a
tool to compare structural differences if any between
normal (i.e. calvarial cells) and transformed cells during
various stages of their cell cycle. It is hope that this
project will aid in answering some questions of cellular
transformations in relation to any possible CaM
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activities.
In summary, it is difficult to predict whether CaM
redistribution is a cause or sequence of a secretory or
metabolic process since, it is so widely distributed: part
cytosolic, in part reversibly bound to subcellular
structures (1, 13 ,) and intra-extracellularly distributed
in sperm and testis, (79).
The question of fundamental importance, whether CaM is
the major calcium binding protein regulating bone
apposition and resorption, remains to be answered. The
answer awaits future investigations. Further clarification
of the calcium-CaM interactions in cancer cells will be of
great assistance in understanding what role this metal-
protein complex might play in cancer cell growth.
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TABLE-I
RESULTS OF THE PROTEIN-A GOLD TECHNIQUE IN THE ROS 17/2.8
CELLS *
SAMPLE NUCLEUS CYTOPLASM EMBEDDING MATERIAL
EXPERIMENTAL GROUP-STATISTICS:
MEAN
SEM
28.1
(+/- 4.2)
20.0
(+/- 3.6)
4.0
(+/- .75)
CONTROL GROUP-STATISTICS:
MEAN
SEM
o
o
.33
(+/- .11)
.17
(+j- .09)
LEGEND *
1. Results were obtained by counting the number of gold
particles found in cells from 18 random pictures from the
experimental group and 18 random pictures from the control
group. Most pictures were taken at the same level of
magnification for evaluations.
2. Results are reported as the mean +j- the standard error
of the mean (SEM).
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Fig.2~Photograph demonstrating the insertion of an elastic
band (.25mm thickness) between the first and second rat
maxillary molars to induce orthodontic tooth movement
taken from Waldo (1953).
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Fig.3-Drawing showing the effects of the insertion of the
elastic band (.25 mm thickness) between the first and
second maxillary molars of the Sprague Dawley rat taken
from Roberts (1974).
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Fig.4-Photograph showing a dissected maxilla from a
Sprague Dawley rat demonstrating the retention of the
elastic band between the first and second maxillary
molars three days after insertion of the elastic.
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Fig.5-Photograph of the rat maxillary molar after the
insertion of the elastic between the first and second
maxillary molars. Immunofluorescence staining (arrow)
is seen on the cells bordering the pulp chamber (PC).
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Fig.6-Photograph showing immunofluorescence staining even
without the insertion of the elastic between the first and
second maxillary molars. Immunofluorescence can be
observed on: the root canal of the molar (A), cementa
enamel junction (B) and alveolar mucosa (C). A faint anti-
CaM labelling was found on the alveolar bone (D).
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Fig.7-Picture of a section of the periodontium of a
Sprague Dawley rat after the insertion of the elastic
between the maxillary molars. Immunofluorescence staining
can be observed on the alveolar bone (A), periodontal
ligament (B) and root canal of the rat maxillary first
molar (C).
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Fig.8-Photograph revealing generalized immuno-labelling of
the alveolus (A) of a Sprague Dawley rat even without any
induction of tooth movement.
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Fig.9-Picture showing immuno-labelling after the insertion
of the elastic between the maxillary molars. Immuno-
flurescence can be seen on the periodontal ligament (AfC)
and interradicular bone (B) surrounding the mesial and
distal roots of the rat maxillary first molar.
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Fig.lO-Photograph of the anti-CaM immuno-fluorescence
after the induction of tooth movement. staining was found
on the periodontal ligament (B) between the first (A) and
second (C) maxillary molars.
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Fig.II-Picture revealing immuno-labelling of a section of
the periodontal ligament (B) without the insertion of the
elastic. The root of the maxillary molar (A) is on the
left and the periodontal ligament can be observed on the
right.
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Fig.12-Photograph demonstrating specific immuno-staining
on the alveolar bone area of resorption (B). Observe the
bone (A), the periodontal ligament (C) and the root of the
first maxillary molar (D). Orthodontic tooth movement was
induced against the immunolabelled area of resorption.
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Fig.13-Photograph showing specific immunofluorescence
staining of the sulcular area (arrows) of the rat
maxillary first molar. No elastic was inserted.
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Fig.14-Photograph of a control specimen showing
insignificant amount of non-specific immunofluorescence
staining of the rat maxillary first molar and the
periodontium. Picture was taken under the same conditions
considered for the experimentals.
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Fig.15-Photograph demonstrating the contigous layers
formed by the ROS 17/2.8 cells in culture. Courtesy of Dr.
Barbara Kream.
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Fig.16-Photograph demonstrating intense nuclear (N)
immuno-staining and faint generalized cytoplasmic
labelling of the ROS 17/2.8 cells (Magnification=20X).
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Fig.17-Photograph of a frozen section preparation showing
an intense nuclear (N) immunofluorescence staining and
some cytoplasmic (C) labelling of the ROS 17/2.8 cells
(Magnification=4QX) .
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Fig.18-Photograph of a control incubation of the ROS
17/2.8 cells with a pre-absorbed primary antibody instead
of the experimental primary antibody where no nuclear (N)
staining and insignificant amount of cytoplasmic (C)
labelling can be observed (Magnification=10X).
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Fig.19-Photograph of a control incubation of the ROS 17/
2.8 cells with normal sheep serum instead of the
experimental antibody where no nuclear (N) staining and
insignificant amount of cytoplasmic (C) labelling can be
observed (Magnification=lQX).
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Fig.20-Photograph of control incubation with a non-sense
primary antibody instead of the experimental antibody
revealing a very faint cytoplasmic (C) staining but no
nuclear (N) labelling of the ROS 17/ 2.8 cells. Cells were
prepared as a frozen section (Magnification=40X).
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Fig.21-Photograph of a control incubation with only the
secondary antibody revealing a very faint cytoplasmic (C)
staining but no nuclear (N) labelling of the ROS 17/ 2.8
cells (Magnification=40X).
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Fig.22-Electron-micrograph of a section of the ROS 17/2.8
cells showing anti-CaM nuclear (N) labelling on the cell
on the left. An area of densely distributed gold particles
can be observed on the cytoplasm (C) of the other cell in
the field. Note the absence of particles between the cells
(Magnification=6600X) .
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Fig.23-Electron-micrograph of a section of a ROS 17/2.8
cell demonstrating anti-Calmodulin immuno-labelling on the
nuclear components including the nucleolus (No)
(Magnification=10,500X) .
Fig.24-Electron-micrograph of a portion of a ROS 17/2.8
cell showing gold particles in the nucleus (N), on nuclear
membrane (NM) and some in the cytoplasm (C) (Magnifica-
tion=10, 500X) .
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Fig.2S-Electron-micrograph demonstrating cytoplasmic
labelling of the rat osteosarcoma cellon the left.
Immuno-staining can be seen in the nucleus (N), and
cytoplasm (C) of the cellon the right of the field. Only
few gold particles can be observed on the embedding
material (EM) (Magnification=13,SOOX).
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Fig.26-Electron-micrograph of a section of the nucleus (N)
and cytoplasm (C) of a ROS 17/2.8 cell. Nuclear and
cytoplasmic immuno-staining was observed (Magnification=
25,OOOX).
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Fig.27-Electron-micrograph of a control incubation with a
pre-absorbed antibody instead of the experimental antibody
demonstrating absence of anti-CaM immuno-Iabelling on the
ROS 17/2.8 cell (Magnification=8900X).
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Fig.28-Electron-micrograph of a control incubation with
normal sheep serum instead of the experimental antibody
showing no immuno-staining on the nucleus and cytoplasm of
a ROS 17/2.8 cell (Magnification=8900X).
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Fig.29-Electron-micrograph of a control incubation with
only the secondary antibody. Absence of anti-CaM labelling
was found on the section (Magnification=8900X).
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Fig.30-Electron-micrograph of a control incubation with a
non-sense primary antibody instead of the experimental
antibody. The section revealed a possible non-specific
immuno-Iabelling of one gold particle (arrow) on the
cytoplasm of a ROS 17/2.8 cell (Magnification=8900X).
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